We are live on ! Find out more
HAE icon

Haemonetics

197 hedge funds and large institutions have $2.11B invested in Haemonetics in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 79 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 13

13% more capital invested

Capital invested by funds: $1.87B → $2.11B (+$240M)

9% more funds holding

Funds holding: 180197 (+17)

0.52% more ownership

Funds ownership: 101.01%101.53% (+0.52%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

19% less repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 79

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $486K

Holders
197
Holders Change
+17
Holders Change %
+9.44%
% of All Funds
4.92%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
33
Increased
64
Reduced
79
Closed
13
Calls
Puts
$486K
Net Calls
-$486K
Net Calls Change
-$935K
Name Holding Trade Value Shares
Change
Change in
Stake
Acadian Asset Management
76
Acadian Asset Management
Massachusetts
$2.74M +$1.99M +52,879 +346%
SSA
77
Schonfeld Strategic Advisors
New York
$2.55M +$2.39M +63,505 New
Deutsche Bank
78
Deutsche Bank
Germany
$2.41M -$5.86M -155,325 -72%
New York State Common Retirement Fund
79
New York State Common Retirement Fund
New York
$2.38M +$56.6K +1,500 +3%
Bessemer Group
80
Bessemer Group
New Jersey
$2.32M +$109K +2,900 +5%
D.E. Shaw & Co
81
D.E. Shaw & Co
New York
$2.28M -$2.36M -62,480 -52%
CIM
82
Confluence Investment Management
Missouri
$2.23M -$24.2K -643 -1%
Comerica Bank
83
Comerica Bank
Texas
$2.23M +$122K +3,233 +6%
PP
84
Prospector Partners
Connecticut
$2.02M
Two Sigma Advisers
85
Two Sigma Advisers
New York
$2.01M +$1.34M +35,595 +249%
KeyBank National Association
86
KeyBank National Association
Ohio
$1.86M +$55.8K +1,480 +3%
American Century Companies
87
American Century Companies
Missouri
$1.83M +$1.71M +45,441 New
HHC
88
Hutchin Hill Capital
New York
$1.79M +$1.68M +44,500 New
SFM
89
Systematic Financial Management
New Jersey
$1.79M -$92.4K -2,450 -5%
State of Tennessee, Department of Treasury
90
State of Tennessee, Department of Treasury
Tennessee
$1.66M
NFA
91
Nationwide Fund Advisors
Ohio
$1.56M -$71.6K -1,898 -5%
State Board of Administration of Florida Retirement System
92
State Board of Administration of Florida Retirement System
Florida
$1.55M -$138K -3,660 -9%
TPSF
93
Texas Permanent School Fund
Texas
$1.51M -$52.8K -1,401 -4%
AIG
94
American International Group
New York
$1.51M -$18.7K -495 -1%
Public Sector Pension Investment Board (PSP Investments)
95
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.47M +$30.2K +800 +2%
MLICM
96
Metropolitan Life Insurance Company (MetLife)
New York
$1.41M -$123K -3,254 -9%
Manulife (Manufacturers Life Insurance)
97
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.39M -$2.26K -60 -0.2%
CC
98
Cipher Capital
New York
$1.34M +$32.4K +860 +3%
SO
99
STRS Ohio
Ohio
$1.21M -$37.7K -1,000 -3%
PI
100
PineBridge Investments
New York
$1.2M +$876K +23,223 +356%

HAE Hedge Fund Activity: Q4 2016 in Review

197 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q4 2016, worth a combined $2.11B — up 13% from $1.87B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new HAE positions and 13 closed out — a net gain of 20 holders — while 64 added to existing stakes and 79 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $43.4M. The largest seller was Fidelity Investments, cutting an estimated $34.9M.

  • 197 institutional investors held Haemonetics (HAE) as of Q4 2016, up from 180 in Q3 2016.
  • Funds reported $2.11B of Haemonetics stock for Q4 2016, up 13% quarter-over-quarter.
  • 33 funds opened new Haemonetics positions in Q4 2016 and 13 closed out, a net change of +20 holders.
  • The largest Haemonetics buyer in Q4 2016 was HealthCor Management, an estimated $43.4M added.
  • The largest Haemonetics seller in Q4 2016 was Fidelity Investments, an estimated $34.9M sold.

Based on aggregated 13F filings for Q4 2016.